12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Other News

Modulation Therapeutics, Multiple Myeloma Research Foundation (MMRF) cancer news

Modulation Therapeutics received a $500,000 grant from the foundation's Biotech Investment Award program to develop MTI-101 to treat...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >